Your browser doesn't support javascript.
loading
SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma.
Ishibashi, Mariko; Takahashi, Risa; Tsubota, Asako; Sasaki, Makoto; Handa, Hiroshi; Imai, Yoichi; Tanaka, Norina; Tsukune, Yutaka; Tanosaki, Sakae; Ito, Shigeki; Asayama, Toshio; Sunakawa, Mika; Kaito, Yuta; Kuribayashi-Hamada, Yasuko; Onodera, Asaka; Moriya, Keiichi; Komatsu, Norio; Tanaka, Junji; Odajima, Takeshi; Sugimori, Hiroki; Inokuchi, Koiti; Tamura, Hideto.
Afiliação
  • Ishibashi M; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Takahashi R; Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan.
  • Tsubota A; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Sasaki M; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Handa H; Division of Hematology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
  • Imai Y; Department of Hematology, Gunma University, Gunma, Japan.
  • Tanaka N; Department of Hematology and Oncology, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Tsukune Y; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
  • Tanosaki S; Division of Hematology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
  • Ito S; Department of Hematology, The Fraternity Memorial Hospital, Tokyo, Japan.
  • Asayama T; Department of Hematology/Oncology, Iwate Medical University School of Medicine, Iwate, Japan.
  • Sunakawa M; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Kaito Y; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Kuribayashi-Hamada Y; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Onodera A; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Moriya K; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Komatsu N; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Tanaka J; Division of Hematology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
  • Odajima T; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
  • Sugimori H; Faculty of Health Science, Daito Bunka University School of Sports and Health Science, Saitama, Japan.
  • Inokuchi K; Department of Preventive Medicine, Daito Bunka University Graduate School of Sports and Health Science, Saitama, Japan.
  • Tamura H; Department of Hematology, Nippon Medical School, Tokyo, Japan.
Mol Cancer Res ; 18(4): 632-643, 2020 04.
Article em En | MEDLINE | ID: mdl-31974290
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema de Sinalização das MAP Quinases / Família de Moléculas de Sinalização da Ativação Linfocitária / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema de Sinalização das MAP Quinases / Família de Moléculas de Sinalização da Ativação Linfocitária / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão